Early-stage NSF-backed ZeoVation is a small, research-driven materials company with NSF SBIR backing and ongoing R&D on antimicrobial additives, presenting a target profile for grant-backed pilot collaborations and early-stage pilot programs in life sciences and consumer product segments.

Antimicrobial & sunscreen Core offerings include a patented antimicrobial additive and a long-lasting broad-coverage sunscreen active, suggesting sales opportunities in healthcare products, personal care, and outdoor consumer goods seeking enhanced protection and stability.

Strategic partnerships Recent financing and proximity to universities and commercialization programs indicate openness to partnerships, licensing, or co-development deals with larger chemical or materials suppliers aiming to augment product portfolios with advanced zeolite-based technologies.

Small team, agile With a 2–10 employee footprint, ZeoVation can be a nimble partner for agile pilots, fast iteration, and close collaboration on formulation, testing, and scale-up for select customers willing to engage in short to mid-term development programs.

Market positioning Revenue under one million and a funding runway around the low single to mid million range suggest a need for early adopter customers and channel partners in specialty chemicals, coatings, and consumer care sectors to drive initial revenue and validate market fit.